Skip to main content

Advertisement

Log in

Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Cell therapy for stress urinary incontinence (SUI) management has been experienced with encouraging results.

Methods

We conducted an open prospective study on 12 women presenting severe SUI with fixed urethra, after previous failed surgical management. Patients underwent intrasphincteric injections of autologous progenitor muscular cells isolated from a biopsy of deltoid muscle. Primary endpoint focused on safety (measurement of Q max variation after 3 months). Secondary endpoints assessed side effects and efficacy.

Results

No variation was diagnosed on Q max measurements. Efficacy data show that three of 12 patients are dry at 12 months, seven other patients are improved on pad test but not on voiding diary, and two patients were slightly worsened by the procedure. Quality of life was improved in half of patients.

Conclusions

Cell therapy for severe multioperated cases of SUI is a mini-invasive, feasible, and safe procedure that can improve urinary condition in as a second line therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

ISD:

Intrinsic sphincter deficiency

PFME:

Pelvic floor muscle exercises

PVR:

Post-voiding residual

Q max :

Maximum urinary flow rate

QoL:

Quality of life

SUI:

Stress urinary incontinence

UI:

Urinary incontinence

UPP:

Urethral pressure profile

UTI:

Urinary tract infection

References

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al (2003) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49

    Article  PubMed  Google Scholar 

  2. Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367:57–67

    Article  PubMed  Google Scholar 

  3. Pajoncini C, Costantini E, Guercini F, Bini V, Porena M (2003) Clinical and urodynamic features of intrinsic sphincter deficiency. Neurourol Urodyn 22:264–268

    Article  PubMed  Google Scholar 

  4. Haab F, Zimmern PE, Leach GE (1996) Female stress urinary incontinence due to intrinsic sphincteric deficiency: recognition and management. J Urol 156:3–17

    Article  CAS  PubMed  Google Scholar 

  5. Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473

    PubMed  Google Scholar 

  6. Mariappan P, Alhasso A, Ballantyne Z, Grant A, N’Dow J (2007) Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 51:67–74

    Article  CAS  PubMed  Google Scholar 

  7. Wilson TS, Lemack GE, Zimmern PE (2003) Management of intrinsic sphincteric deficiency in women. J Urol 169:1662–1669

    Article  PubMed  Google Scholar 

  8. Kiilholma P, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ (1993) Complications of Teflon injections for stress urinary incontinence. Neurourol Urodyn 12:131–137

    Article  CAS  PubMed  Google Scholar 

  9. Rogers RG (2008) Urinary stress incontinence in women. N Engl J Med 358:1029–1036

    Article  CAS  PubMed  Google Scholar 

  10. Pesce F (2004) Current management of stress urinary incontinence. BJU Int 94(S1):8–13

    Article  PubMed  Google Scholar 

  11. Torrente Y, Belicchi M, Marchesi C, Dantona G, Cogiamanian F, Pisati F et al (2007) Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 16:563–577

    CAS  PubMed  Google Scholar 

  12. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Myoblast transplantation for heart failure. Lancet 357:279–280

    Article  PubMed  Google Scholar 

  13. Strasser H, Berjukow S, Marksteiner R, Margreiter E, Hering S, Bartsch G et al (2004) Stem cell therapy for urinary stress incontinence. Exp Gerontol 39:1259–1265

    Article  PubMed  Google Scholar 

  14. Praud C, Sebe P, Biérinx AS, Sebille A (2007) Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting. Cell Transplant 16:741–749

    PubMed  Google Scholar 

  15. Peyromaure M, Sèbe P, Praud C, DeRocle G, Potin N, Pincet C et al (2004) Fate of implanted syngenic muscle precursor cells in striated urethral sphincter of female rats: perspectives for treatment of urinary incontinence. Urology 64:1037–1041

    Article  PubMed  Google Scholar 

  16. Yiou R, Yoo JJ, Atala A (2003) Restoration of functional motor units in a rat model of sphincter injury by muscle progenitor cell autografts. Transplantation 76:1053–1060

    Article  PubMed  Google Scholar 

  17. Yokoyama T, Yoshimura N, Dhir R, Qu Z, Fraser MO, Kumon H et al (2001) Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 165:271–276

    Article  CAS  PubMed  Google Scholar 

  18. Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N et al (2000) Preliminary results of myoblasts injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractibility. Neurourol Urodyn 19:279–287

    Article  CAS  PubMed  Google Scholar 

  19. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R et al (2008) 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:881–883

    Article  CAS  PubMed  Google Scholar 

  20. Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 43:391–404

    Article  PubMed  Google Scholar 

  21. Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B et al (2005) Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12:1130–1141

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

Christelle Doucet is employed by Celogos. Christian Pinset is shareholder of Celogos and the inventor and the owner of the patent protecting the process of manufacturing cells. Sixtina Gil Diez de Medina received payment from HRA Pharma, a firm that holds shares in CELOGOS capital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Nicolas Cornu.

Additional information

Philippe Sèbe and Christelle Doucet have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sèbe, P., Doucet, C., Cornu, JN. et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study. Int Urogynecol J 22, 183–189 (2011). https://doi.org/10.1007/s00192-010-1255-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-010-1255-5

Keywords

Navigation